Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ulrik Moerch"'
Autor:
Edward V Loftus, Séverine Vermeire, Brian G Feagan, Franck-Olivier Le Brun, Alessandra Oortwijn, Ulrik Moerch, William J Sandborn, Toshifumi Hibi
Background and Aims Corticosteroid-free remission is an important treatment goal for patients with ulcerative colitis [UC]. The corticosteroid-sparing effects of filgotinib, an oral, Janus kinase 1 preferential inhibitor, were assessed in SELECTION,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac7c5a8300e32bb40854ac22960ca48
https://lirias.kuleuven.be/handle/20.500.12942/702613
https://lirias.kuleuven.be/handle/20.500.12942/702613
Autor:
Edward V. Loftus, Yan Zhou, Sally Zhao, Chohee Yun, Mamoru Watanabe, Jeremy Hsieh, Ulrik Moerch, Stefan Schreiber, Ben Morison, Gerhard Rogler
Publikováno v:
Oral.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e2badadbecb7089d3fe875316da7c29
https://doi.org/10.1136/gutjnl-2021-bsg.10
https://doi.org/10.1136/gutjnl-2021-bsg.10
Autor:
Edward V. Loftus, Xiaopeng Liu, Toshifumi Hibi, William J. Sandborn, Brian G. Feagan, Ben Morison, Severine Vermeire, Ulrik Moerch, Chohee Yun, Sally Zhao, Jeremy Hsieh
Publikováno v:
Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::894854ab464d31091211614c1c132641
https://doi.org/10.1136/gutjnl-2021-bsg.169
https://doi.org/10.1136/gutjnl-2021-bsg.169
Autor:
Gerhard Rogler, Ulrik Moerch, Mamoru Watanabe, Stefan Schreiber, Yan Zhou, Chohee Yun, Sally Zhao, Jeremy Hsieh, Edward V. Loftus
Publikováno v:
Gastroenterology. 160:S-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::254c2135402b653b08ad70b78edc3d99
https://doi.org/10.1016/s0016-5085(21)00836-2
https://doi.org/10.1016/s0016-5085(21)00836-2
Autor:
Lotte, Bjerre Knudsen, Lars Wichmann, Madsen, Søren, Andersen, Kasper, Almholt, Anne S, de Boer, Daniel J, Drucker, Carsten, Gotfredsen, Frederikke Lihme, Egerod, Anne Charlotte, Hegelund, Helene, Jacobsen, Søren Dyring, Jacobsen, Alan C, Moses, Anne-Marie, Mølck, Henriette S, Nielsen, Jette, Nowak, Helene, Solberg, Tu D L, Thi, Milan, Zdravkovic, Ulrik, Moerch
Publikováno v:
Endocrinology. 151:1473-1486
Liraglutide is a glucagon-like peptide-1 (GLP-1) analog developed for type 2 diabetes. Long-term liraglutide exposure in rodents was associated with thyroid C-cell hyperplasia and tumors. Here, we report data supporting a GLP-1 receptor-mediated mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79b3718a29c823e2c2079c2f1b7e568
https://doi.org/10.1210/en.2009-1272
https://doi.org/10.1210/en.2009-1272
Publikováno v:
Cytometry Part A. :495-500
Background: Fluorescence-activated cell sorting (FACS) is an attractive technique for gene or protein expression studies in rare cell populations. For cell types where specific surface markers are not known, intracellular markers can be used. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58eed93f13f8b87e3f57b437cf3a4463
https://doi.org/10.1002/cyto.a.20418
https://doi.org/10.1002/cyto.a.20418
Autor:
David Schrama, Mads Hald Andersen, Per thor Straten, Jürgen C. Becker, Ralph A. Reisfeld, Tina Seremet, Ulrik Moerch, Per Guldberg, Claudia Siedel
Publikováno v:
European Journal of Immunology. 31:250-258
Immunity to tumors relies on recirculating antigen-specific T cells. Whilst induction of antigen-specific T cells by immunotherapy has been convincingly proven, direct evidence for recirculation of such cells is still lacking. Here, employing a recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1444949833cce073dd56e67f5c33cb0a
https://doi.org/10.1002/1521-4141(200101)31:1<250::aid-immu250>3.0.co
https://doi.org/10.1002/1521-4141(200101)31:1<250::aid-immu250>3.0.co
Autor:
Per thor Straten, Jesper Zeuthen, David Schrama, Jürgen C. Becker, Tina Seremet, Per Guldberg, Ulrik Moerch
Publikováno v:
Cancer immunology, immunotherapy : CII. 49(8)
B16 is a murine melanoma of C57Bl/6 origin, which rapidly develops as a tumor when inoculated into syngeneic immunocompetent hosts. Nevertheless, B16 tumors are considered to be immunogenic since tumor regression can be induced by means of immunother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2641242a2967e936a672b03b8af346d
https://pubmed.ncbi.nlm.nih.gov/11043849
https://pubmed.ncbi.nlm.nih.gov/11043849
Publikováno v:
Journal of Investigative Dermatology. 114:738-739
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80c5d799eb98a995f8a3b663378d2eb
https://doi.org/10.1046/j.1523-1747.2000.00932.x
https://doi.org/10.1046/j.1523-1747.2000.00932.x